活性氮介导的内皮细胞株损伤及人参皂苷Rg1对Aβ肽源性活性氮损伤保护机制研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
第一部分外源性活性氮供体GSNO对内皮细胞损伤及机制研究
     阿尔茨海默病(Alzheimer's disease,AD)的病变过程中可伴有活性氮(reactivenitrogen species,RNS)大量生成,但RNS对内皮细胞的损伤机制至今仍未阐明。本研究选择外源性RNS供体S-亚硝酰谷胱甘肽(S-nitrosoglutathione,GSNO)直接作用于内皮细胞的模型,试图揭示RNS和内皮细胞损伤之间内在的病理生理关联性。研究采用在培养的EA.hy926内皮细胞株(下简称内皮细胞)体系中加入GSNO(0.5 mM),通过DAPI染色和PI流式细胞术检测到内皮细胞呈浓度和时间依赖性凋亡。结果显示,细胞内活性氧(reactive oxygen species,ROS)增加的同时伴随线粒体膜电位(△Ψm)降低。尤为重要的发现是该损伤过程中,过氧亚硝酸阴离子形成和线粒体促凋亡蛋白丝氨酸蛋白酶(Omi/HtrA2)和细胞色素C(Cytochrome C,Cyt C)从线粒体释放至胞浆中,启动了凋亡终端蛋白caspase 3的活化,而在这一过程中未检测到死亡受体途径相关蛋白变化,表明GSNO可通过ROS-线粒体信号途径诱导细胞凋亡。在该体系中加入NADPH氧化酶抑制剂apocynin,ROS清除剂TEMPOL和Omi/HtrA2抑制剂ucf-101,均能显著抑制caspase3的活化发挥抗GSNO诱导凋亡的作用。上述结果进一步证实了外源性GSNO可引起内皮细胞线粒体依赖性损伤,该过程中ROS过表达及线粒体促凋亡蛋白Omi/HtrA2移位,在RNS诱导的内皮细胞凋亡中起着至关重要的作用,药物调控这些相关途径有望发挥显著的抗内皮细胞损伤效应。
     第二部分Aβ肽源性RNS致内皮细胞损伤及人参皂苷Rg1保护机制研究
     β淀粉样(beta-amyloid,Aβ)肽在脑实质和脑微血管上沉积是AD的主要病理特征,但Aβ肽介导的神经元和内皮细胞损伤机制仍不清楚。鉴于本文第一部分研究结果表明,GNSO具有致内皮细胞凋亡作用。本部分研究首先探讨Aβ_(25-35)肽损伤内皮细胞模型是否有RNS产生及其损伤特征。并在此基础上,评价了人参皂苷Rg1的保护机制。选择25μM的Aβ肽作用于内皮细胞,引起细胞存活率减少,乳酸脱氢酶释放和显著的细胞凋亡特征,同时伴随细胞内NO过表达和氧化亚硝基阴离子(Peroxynitrite anion,ONOO~-)大量生成,和蛋白酪氨酸硝基化。而加入人参皂苷Rg1预处理可显著减轻Aβ肽所引起的上述细胞毒性,显著减少Aβ肽诱导的NO过表达和蛋白酪氨酸硝基化。并可部分逆转Aβ肽导致的线粒体△Ψm降低,Bcl-2/Bax下调,Cyt C释放及caspase 3激活,提示人参皂苷Rg1预处理具有抗Aβ肽导致的内皮细胞线粒体依赖性凋亡作用。此外,Aβ肽尚能在激活p38-MAPK的同时抑制ERK的磷酸化,并激活NF-κB核转录及I-κB的磷酸化,这些效应均能不同程度地被人参皂苷Rg1逆转。另鉴于人参皂苷Rg1的核心结构与甾体类似,为论证保护作用机制是否涉及相关受体,本研究尚通过甾体激素受体拮抗剂和ERK抑制剂对抗,结果表明两者均能部分减弱Rg1的保护效应。上述试验结果提示,Aβ肽致内皮细胞损伤与RNS所致的蛋白硝基化和凋亡有关,糖皮质激素受体激活和ERK减少可能涉及人参皂苷Rg1的上述抗凋亡作用,同时通过其抗氧化效应,阻断下游级联反应而发挥保护作用。
     总结:
     1.体外实验体系中过量活性氮供体GSNO作用于内皮细胞,可引起ROS的过量生成伴随NO/过氧化亚硝基阴离子信号途径的激活,诱导线粒体依赖性凋亡。
     2.Aβ肽介导的内皮细胞损伤与RNS的生成关系密切,人参皂苷Rg1主要通过其抗氧化、抗线粒体依赖性凋亡和抑制蛋白酪氨酸硝基化作用发挥内皮细胞保护效应。
Chapter1 The mechanisms of ectogenesis RNS donor S-nitrosoglutathione (GSNO)-induced damage in human endothelial cells
     The course of Alzheimer's disease accompanied by a large generation of RNS,but the mechanisms of RNS-induced endothelial cell injury has not been clarified. Furthermore,the pathophysiological relevance of S-nitrosoglutathione(GSNO)-induced endothelial cell injury remains unclear.The main objective of this study was to elucidate the molecular mechanisms of GSNO-induced oxidative stress in endothelial cells.Morphological evaluation through DAPI staining and propidium iodide(PI) flow cytometry was used to detect apoptosis.In cultured EA.hy926 endothelial cells, exposure to GSNO led to a time- and dose-dependent apoptotic cascade.When intracellular reactive oxygen species(ROS) production was monitored in GSNO-treated cells by diaminofluorescein-FM,we observed elevated ROS levels and a concomitant loss in mitochondrial membrane potential,indicating that GSNO-induced death signaling is mediated through a ROS-mitochondrial pathway.Importantly,we found that peroxynitrite formation and omi/HtrA2 release from mitochondria were involved in this phenomenon,whereas changes of death-receptor dependent signaling were not detected in the same context.The inhibition of NADPH oxidase activation and omi/HtrA2 by a pharmacological approach provided significant protection against caspase 3 activation as well as GSNO-induced cell death,confirming that GSNO triggers the death cascade in endothelial cells in a mitochondria-dependent manner. Taken together,ROS overproduction and loss of mitochondrial omi/HtrA2 play a pivotal role in reactive nitrogen species-induced cell death,and the modulation of these pathways can be of significant therapeutic benefit.
     Chapter2 The effect of RNS in Aβ-mediated damage to EA.hy926 endothelial cells and the protective mechanisms of ginsenoside Rg1
     The deposition of beta-amyloid(Aβ) in the brain parenchyma and cerebrovasculature has been characterized in Alzheimer's disease(AD),but the precise mechanisms of Aβ-mediated neuronal and endothelial insult remains unclear.In the present study,we attempted to evaluate the potential mechanisms of Aβ-mediated insult in endothelial cells as well as protective effect of Ginsenocide Rg1.In cultured EA.hy926 endothelial cells,Aβ_(25-35)(25μM) treatment induced cell toxicity, characterized by decreased cell viability,lactate dehydrogenase(LDH) release,and significant apoptotic characteristics,which is associated with both the overproduction of intracellular ROS and loss of mitochondrial membrane potential.By contrast, cytotoxicity of Aβ_(25-35) was significantly reversed by pre-incubation of Rgl in endothelial cells.Furthermore,Rgl prevented Aβ_(25-35)-induced nitric oxide overproduction and protein tyrosine nitration in same context.Immunoblotting results revealed that upregulation of iNOS and nitrotyrosine,Bcl-2/Bax downregulation, Cytochrome C release and activation of caspase 3 in Aβ_(25-35)-treated cells were partially blocked by Rg1.Additionally,Aβ25-35 triggered the activation of p38-MAPK and inhibited the phosphorylation of ERK,and these effect were effectively suppressed by Rg1 treatment,whereas glucocorticoid receptor antagonist RU 486 and MEK inhibitor U0126 both weakened the protective effect of Rg1.Taken together,our results suggest that Rgl protects EA.hy926 endothelial cells against Aβ_(25-35)-induced apoptotic cascade through suppressing peroxynitrite formation and anti-oxidative mechanisms.
     Summary:
     1.We demonstrate that excessive ROS generation and peroxynitrite formation resulting from GSNO treatment accounts for initiation of GSNO/NO-induced endothelial injury in vitro.
     2.Our results indicate that NO-mediated intrinsic pathway signaling constitutes a critical component of apoptotic signaling in Aβ-mediated endothelial cell death.Rg1 is a potential endothelial protective compound against Aβ_(25-35) insult which was exerted by suppressing protein tyrosine nitration and anti-oxidative mechanisms.
引文
[1]Shimizu H,Ghazizadeh M,Sato S,Oguro T,Kawanami O.Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease[J].J Clin Neurosci,2009,16(2):277-282
    [2]Zhu X,Smith MA,Honda K,Aliev G,Moreira PI,Nunomura A,Casadesus G,Harris PL,Siedlak SL,Perry G.Vascular oxidative stress in Alzheimer disease[J].J Neurol Sci,2007,257(1-2):240-246
    [3]Zipser BD,Johanson CE,Gonzalez L,Berzin TM,Tavares R,Hulette CM,Vitek MP,Hovanesian V,Stopa EG.Microvascular injury and blood-brain barrier leakage in Alzheimer's disease[J].Neurobiol Aging,2007,28(7):977-986
    [4]Zlokovic BV.The blood-brain barrier in health and chronic neurodegenerative disorders[J].Neuron,2008,57(2):178-201
    [5]Hamel E,Nicolakakis N,Aboulkassim T,Ongali B,Tong XK.Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease[J].Exp Physiol,2008,93(1):116-120
    [6]Malinski T.Nitric oxide and nitroxidative stress in Alzheimer's disease[J].J Alzheimers Dis,2007,11(2):207-218
    [7]van den Tweel ER,Nijboer C,Kavelaars A,Heijnen CJ,Groenendaal F,van Bel F.Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat brain[J].J Neuroimmunol,2005,167(1-2):64-71
    [8]Zou MH,Shi C,Cohen RA.Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite[J].J Clin Invest,2002,109(6):817-826
    [9]Cassina P,Peluffo H,Pehar M,Martinez-Palma L,Ressia A,Beckman JS,Estevez AG,Barbeito L.Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis[J].J Neurosci Res,2002,67(1):21-29
    [10]Wang XY,Chen J,Zhang JT.[Effect of ginsenoside Rgl on learning and memory impairment induced by beta-amyloid peptide(25-35) and its mechanism of action][J].Yao Xue Xue Bao,2001,36(1):1-4
    [11]Zhang YF,Fan XJ,Li X,Peng LL,Wang GH,Ke KF,Jiang ZL.Ginsenoside Rgl protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels[J].Eur J Pharmacol,2008,586(1-3):90-99
    [12]Zheng M,Qu L,Lou Y.Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat[J].Phytother Res,2008,22(5):597-604
    [13]Wassmann S,Wassmaim K,Nickenig G.Modulation of oxidant and antioxidant enzyme expression and function in vascular cells[J].Hypertension,2004,44(4):381-386
    [14]Navarro-Antolin J,Redondo-Horcajo M,Zaragoza C,Alvarez-Barrientos A,Fernandez AP,Leon-Gomez E,Rodrigo J,Lamas S.Role of peroxynitrite in endothelial damage mediated by Cyclosporine A[J].Free Radic Biol Med,2007,42(3):394-403
    [15]Manevich Y,Al-Mehdi A,Muzykantov V,Fisher AB.Oxidative burst and NO generation as initial response to ischemia in flow-adapted endothelial cells[J].Am J Physiol Heart Circ Physiol,2001,280(5):H2126-2135
    [16]Walford GA,Moussignac RL,Scribner AW,Loscalzo J,Leopold JA.Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways[J].J Biol Chem,2004, 279(6):4425-4432
    [17]Pearce LL,Epperly MW,Greenberger JS,Pitt BR,Peterson J.Identification of respiratory complexes Ⅰ and Ⅲ as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide[J].Nitric Oxide,2001,5(2):128-136
    [18]Pacher P,Beckman JS,Liaudet L.Nitric oxide and peroxynitrite in health and disease[J].Physiol Rev,2007,87(1):315-424
    [19]Radi R.Nitric oxide,oxidants,and protein tyrosine nitration[J].Proc Natl Acad Sci U S A,2004,101(12):4003-4008
    [20]Murray J,Taylor SW,Zhang B,Ghosh SS,Capaldi RA.Oxidative damage to mitochondrial complex Ⅰ due to peroxynitrite:identification of reactive tyrosines by mass spectrometry[J].J Biol Chem,2003,278(39):37223-37230
    [21]Han F,Ali Raie A,Shioda N,Qin ZH,Fukunaga K.Accumulation of beta-amyloid in the brain microvessels accompanies increased hyperphosphorylated tau proteins following microsphere embolism in aged rats[J].Neuroscience,2008,153(2):414-427
    [22]Han F,Shirasaki Y,Fukunaga K.Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain[J].J Neurochem,2006,99(1):97-106
    [23]Reid AB,Kurten RC,McCullough SS,Brock RW,Hinson JA.Mechanisms of acetaminophen-induced hepatotoxicity:role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes[J].J Pharmacol Exp Ther,2005,312(2):509-516
    [24]Boczkowski J,Lisdero CL,Lanone S,Carreras MC,Aubier M,Poderoso JJ.Peroxynitrite-mediated mitochondrial dysfunction[J].Biol Signals Recept,2001,10(1-2):66-80
    [25]Suzuki Y,Takahashi-Niki K,Akagi T,Hashikawa T,Takahashi R.Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways[J].Cell Death Differ,2004,11(2):208-216
    [26]Babich H,Zuckerbraun HL.In vitro cytotoxicity of glyco-S-nitrosothiols.a novel class of nitric oxide donors[J].Toxicol In Vitro,2001,15(3):181-190
    [27]Lin DY,Ma WY,Duan SJ,Zhang Y,Du LY.Real-time imaging of viable-apoptotic switch in GSNO-induced mouse thymocyte apoptosis[J].Apoptosis,2006,11(8):1289-1298
    [28]He J,Kang H,Yan F,Chen C.The endoplasmic reticulum-related events in S-nitrosoglutathione-induced neurotoxicity in cerebellar granule cells[J].Brain Res,2004,1015(1-2):25-33
    [29]Lima B,Lam GK,Xie L,Diesen DL,Villamizar N,Nienaber J,Messina E,Bowles D,Kontos CD,Hare JM,Stamler JS,Rockman HA.Endogenous S-nitrosothiols protect against myocardial injury[J].Proc Natl Acad Sci U S A,2009,106(15):6297-6302
    [30]Zaman K,Hanigan MH,Smith A,Vaughan J,Macdonald T,Jones DR,Hunt JF,Gaston B.Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells[J].Am J Respir Cell Mol Biol,2006,34(4):387-393
    [31]Bouis D,Hospers GA,Meijer C,Molema G,Mulder NH.Endothelium in vitro:a review of human vascular endothelial cell lines for blood vessel-related research[J].Angiogenesis,2001,4(2):91-102
    [32]Edgell CJ,Haizlip JE,Bagnell CR,Packenham JP,Harrison P,Wilbourn B,Madden VJ.Endothelium specific Weibel-Palade bodies in a continuous human cell line,EA.hy926[J].In Vitro Cell Dev Biol,1990,26(12):1167-1172
    [33]Sandau K,Brune B.The dual role of S-nitrosoglutathione(GSNO) during thymocyte apoptosis[J].Cell Signal,1996,8(3):173-177
    [34]Gao L,Shan BE,Chen J,Liu JH,Song DX,Zhu BC.Effects of spider Macrothele raven venom on cell proliferation and cytotoxicity in HeLa cells[J].Acta Pharmacol Sin,2005,26(3):369-376
    [35]Smiley ST,Reers M,Mottola-Hartshorn C,Lin M,Chen A,Smith TW,Steele GD,Jr.,Chen LB.Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1[J].Proc Natl Acad Sci U S A,1991,88(9):3671-3675
    [36]Chi L,Ke Y,Luo C,Gozal D,Liu R.Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo[J].Neuroscience,2007,144(3):991-1003
    [37]Shaamash AH,Elsonosy ED,Zakhari MM,Radwan SH,El-Dien HM.Placental nitric oxide synthase(NOS) activity and nitric oxide(NO) production in normal pregnancy,pre-eclampsia and eclampsia[J].Int J Gynaecol Obstet,2001,72(2):127-133
    [38]Collins-Underwood JR,Zhao W,Sharpe JG,Robbins ME.NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells[J].Free Radic Biol Med,2008,45(6):929-938
    [39]Griendling KK,Minieri CA,Ollerenshaw JD,Alexander RW.Angiotensin Ⅱ stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells[J].Circ Res,1994,74(6):1141-1148
    [40]Althaus J,Siegelin MD,Dehghani F,Cilenti L,Zervos AS,Rami A.The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion[J].Neurochem Int,2007,50(1):172-180
    [41]Liu HR,Gao E,Hu A,Tao L,Qu Y,Most P,Koch WJ,Christopher TA,Lopez BL,Alnemri ES,Zervos AS,Ma XL.Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion[J].Circulation,2005,111(1):90-96
    [42]Cover C,Mansouri A,Knight TR,Bajt ML,Lemasters JJ,Pessayre D,Jaeschke H.Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity[J].J Pharmacol Exp Ther,2005,315(2):879-887
    [43]Beckman JS,Koppenol WH.Nitric oxide,superoxide,and peroxynitrite:the good,the bad,and ugly[J].Am J Physiol,1996,271(5 Pt 1):C1424-1437
    [44]Dash PR,McCormick J,Thomson MJ,Johnstone AP,Cartwright JE,Whitley GS.Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of protein kinase Cepsilon[J].Exp Cell Res,2007,313(16):3421-3431
    [45]Liversidge J,Dick A,Gordon S.Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis[J].Am J Pathol,2002,160(3):905-916
    [46]Klein AM,Kowall NW,Ferrante RJ.Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex[J].Ann N Y Acad Sci,1999,893:314-320
    [47]Xiao XQ,Wang R,Tang XC.Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury[J].J Neurosci Res,2000,61(5):564-569
    [48]Radad K,Gille G,Moldzio R,Saito H,Ishige K,Rausch WD.Ginsenosides Rb1 and Rgl effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells[J].J Neural Transm,2004,111(1):37-45
    [49]Leung KW,Pon YL,Wong RN,Wong AS.Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells[J].J Biol Chem,2006,281(47):36280-36288
    [50]张均田.人参皂甙Rg1和Rb1药理作用的比较[J].基础医学与临床,2000,(05):4-6
    [51]Preston JE,Hipkiss AR,Himsworth DT,Romero IA,Abbott JN.Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell:protection by carnosine, homocarnosine and beta-alanine[J].Neurosci Lett,1998,242(2):105-108
    [52]Chakrabarti S,Vitseva O,Iyu D,Varghese S,Freedman JE.The effect of dipyridamole on vascular cell-derived reactive oxygen species[J].J Pharmacol Exp Ther,2005,315(2):494-500
    [53]Cristina de Assis M,Cristina Plotkowski M,Fierro IM,Barja-Fidalgo C,de Freitas MS.Expression of inducible nitric oxide synthase in human umbilical vein endothelial cells during primary culture[J].Nitric Oxide,2002,7(4):254-261
    [54]Green KN,Peers C.Divergent pathways account for two distinct effects of amyloid beta peptides on exocytosis and Ca(2+) currents:involvement of ROS and NF-kappaB[J].J Neurochem,2002,81(5):1043-1051
    [55]Russell KS,Haynes MP,Sinha D,Clerisme E,Bender JR.Human vascular endothelial cells contain membrane binding sites for estradiol,which mediate rapid intracellular signaling[J].Proc Natl Acad Sci U S A,2000,97(11):5930-5935
    [56]Yip-Schneider MT,Klein PJ,Wentz SC,Zeni A,Menze A,Schmidt CM.Resistance to MEK inhibitors correlates with upregulation of the MEK/ERK pathway in hepatocellular carcinoma cells[J].J Pharmacol Exp Ther,2009:
    [57]Thomas T,McLendon C,Sutton ET,Thomas G.Cerebrovascular endothelial dysfunction mediated by beta-amyloid[J].Neuroreport,1997,8(6):1387-1391
    [58]Thomas T,Sutton ET,Hellermann A,Price JM.Beta-amyloid-induced coronary artery vasoactivity and endothelial damage[J].J Cardiovasc Pharmacol,1997,30(4):517-522
    [59]Beckman JS,Crow JP.Pathological implications of nitric oxide,superoxide and peroxynitrite formation[J].Biochem Soc Trans,1993,21(2):330-334
    [60]Gu X,El-Remessy AB,Brooks SE,Al-Shabrawey M,Tsai NT,Caldwell RB.Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite[J].Am J Physiol Cell Physiol,2003,285(3):C546-554
    [61]Aulak KS,Koeck T,Crabb JW,Stuehr DJ.Dynamics of protein nitration in cells and mitochondria[J].Am J Physiol Heart Circ Physiol,2004,286(1):H30-38
    [62]Tran MH,Yamada K,Nakajima A,Mizuno M,He J,Kamei H,Nabeshima T.Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid beta-peptide-induced cholinergic dysfunction[J].Mol Psychiatry,2003,8(4):407-412
    [63]Su YT,Chang HL,Shyue SK,Hsu SL.Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway[J].Biochem Pharmacol,2005,70(2):229-241
    [64]Je JH,Lee JY,Jung KJ,Sung B,Go EK,Yu BP,Chung HY.NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway[J].FEBS Lett,2004,566(1-3):183-189
    [65]Grethe S,Porn-Ares MI.p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK survival pathway in TNF-alpha induced endothelial apoptosis[J].Cell Signal,2006,18(4):531-540
    [66]Xia C,Wang G,Sun J,Hao H,Xiong Y,Gu S,Shang L,Zheng C.Simultaneous determination of ginsenoside Rg1,Re,Rd,Rb1 and ophiopogonin D in rat plasma by liquid chromatography/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of 'SHENMAI' injection[J].J Chromatogr B Analyt Technol Biomed Life Sci,2008,862(1-2):72-78
    [67]Iadecola C,Zhang F,Niwa K,Eckman C,Turner SK,Fischer E,Younkin S,Borchelt DR,Hsiao KK,Carlson GA.SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein[J].Nat Neurosci,1999,2(2):157-161
    [68]Nestor PJ,Scheltens P,Hodges JR.Advances in the early detection of Alzheimer's disease[J].Nat Med,2004,10 Suppl:S34-41
    [69]Kandimalla KK,Scott OG,Fulzele S,Davidson MW,Poduslo JF.Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid beta Protein[J].PLoS ONE,2009,4(2):e4627
    [70]陈祥慧,肖军.阿尔茨海默病与脑血管疾病危险因素关系的研究进展[J].国际内科学杂志,2008,(12):723-726
    [71]Dawson JD,Anderson SW,Uc EY,Dastrup E,Rizzo M.Predictors of driving safety in early Alzheimer disease[J].Neurology 2009,72(6):521-527
    [72]Cummings JL.Alzheimer's disease[J].N Engl J Med,2004,351(1):56-67
    [73]McEvoy LK,Fennema-Notestine C,Roddey JC,Hagler Jr DJ,Jr.,Holland D,Karow DS,Pung CJ,Brewer JB,Dale AM.Alzheimer Disease:Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment[J].Radiology,2009:
    [74]Abellan van Kan G,Rolland Y,Nourhashemi F,Coley N,Andrieu S,Vellas B.Cardiovascular Disease Risk Factors and Progression of Alzheimer's Disease[J].Dement Geriatr Cogn Disord,2009,27(3):240-246
    [75]Tian J,Shi J,Smallman R,Iwatsubo T,Mann DM.Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls,as cerebral amyloid angiopathy,and the amount of cerebrovascular smooth muscle cells and collagen[J].Neuropathol Appl Neurobiol,2006,32(3):332-340
    [76]刘静,朱兴族,李晓玉.阿尔茨海默病与脑血管病变[J].国外医学(药学分册),2006,(05):348-350
    [77]Kalaria RN.Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease[J].Neurobiol Aging,2008:
    [78]del Zoppo GJ.Virchow's triad:the vascular basis of cerebral injury[J].Rev Neurol Dis,2008,5 Suppl 1:S12-21
    [79]Walker DG,Dalsing-Hernandez JE,Lue LF.Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway:a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease[J].Microvasc Res,2008,75(3):411-419
    [80]O'Callaghan P,Sandwall E,Li JP,Yu H,Ravid R,Guan ZZ,van Kuppevelt TH,Nilsson LN,Ingelsson M,Hyman BT,Kalimo H,Lindahl U,Lannfelt L,Zhang X.Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells[J].Brain Pathol,2008,18(4):548-561
    [81]Watanabe N,Araki W,Chui DH,Makifuchi T,Ihara Y,Tabira T.Glypican-1 as an Abeta binding HSPG in the human brain:its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease[J].FASEB J,2004,18(9):1013-1015
    [82]Tate CC,Shear DA,Tate MC,Archer DR,Stein DG,Laplaca MC.Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain[J].J Tissue Eng Regen Med,2009:
    [83]Zarei M,Damoiseaux JS,Morgese C,Beckmann CF,Smith SM,Matthews PM,Scheltens P,Rombouts SA,Barkhof F.Regional white matter integrity differentiates between vascular dementia and Alzheimer disease[J].Stroke,2009,40(3):773-779
    [84]Stahl R,Dietrich O,Teipel SJ,Hampel H,Reiser MF,Schoenberg SO.White matter damage in Alzheimer disease and mild cognitive impairment:assessment with diffusion-tensor MR imaging and parallel imaging techniques[J].Radiology,2007,243(2):483-492
    [85]Zacchigna S,Lambrechts D,Carmeliet P.Neurovascular signalling defects in neurodegeneration[J].Nat Rev Neurosci,2008,9(3):169-181
    [86]Pluta R.Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain[J].Curr Neurovasc Res,2007,4(2):121-129
    [87] Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease[J]. Dement Geriatr Cogn Disord, 2007, 23(4): 241-245
    [88] Yamada K, Hashimoto T, Yabuki C, Nagae Y, Tachikawa M, Strickland DK, Liu Q, Bu G, Basak JM, Holtzman DM, Ohtsuki S, Terasaki T, Iwatsubo T. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells[J]. J Biol Chem, 2008, 283(50): 34554-34562
    [89] Nazer B, Hong S, Selkoe DJ. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model [J]. Neurobiol Dis, 2008, 30(1): 94-102
    [90] Donahue JE, Johanson CE. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease[J]. J Neuropathol Exp Neurol, 2008, 67(4): 261-270
    [91] Chaney MO, Stine WB, Kokjohn TA, Kuo YM, Esh C, Rahman A, Luehrs DC, Schmidt AM, Stern D, Yan SD, Roher AE. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling[J]. Biochim Biophys Acta, 2005, 1741(1-2): 199-205
    [92] Onyango IG, Tuttle JB, Bennett JP, Jr. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE)[J]. Mol Cell Neurosci, 2005, 29(2): 333-343
    [93] Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products [J]. J Rheumatol, 2008, 35(5): 752-756
    [94] Herring A, Yasin H, Ambree O, Sachser N, Paulus W, Keyvani K. Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice[J]. Brain Pathol, 2008, 18(1): 32-39
    [95] Vilhjalmsson DT, Blondal H, Thormodsson FR. Solubilized cystatin C amyloid is cytotoxic to cultured human cerebrovascular smooth muscle cells[J]. Exp Mol Pathol, 2007, 83(3): 357-360
    [96] Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ, Frosch MP, Hyman BT, Moskowitz MA, Ayata C. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy[J]. Brain, 2007, 130(Pt 9): 2310-2319
    [97] Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, Cirrito JR, Milner E, Holtzman DM, Zipfel GJ. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition[J]. J Neurosci, 2008, 28(50): 13542-13550
    [98] Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins[J]. Neuron, 1995, 15(5): 1203-1218
    [99] Kawarabayashi T, Shoji M, Sato M, Sasaki A, Ho L, Eckman CB, Prada CM, Younkin SG, Kobayashi T, Tada N, Matsubara E, Iizuka T, Harigaya Y, Kasai K, Hirai S. Accumulation of beta-amyloid fibrils in pancreas of transgenic mice[J]. Neurobiol Aging, 1996, 17(2): 215-222
    [100] Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease[J]. J Exp Med, 2007, 204(8): 1999-2008
    [101] Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance[J]. Neurology, 2007, 68(21): 1809-1814
    [102] Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease[J]. Acta Neuropathol, 2008, 115(6): 599-609
    [103] Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease[J]. FASEB J, 2006, 20(3): 426-433
    [104] Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances[J]. Neurobiol Aging, 2008:
    [105] Aho L, Jolkkonen J, Alafuzoff I. Beta-amyloid aggregation in human brains with cerebrovascular lesions[J]. Stroke, 2006, 37(12): 2940-2945
    [106] Stopa EG, Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, Hovanesian V, Hulette CM, Vitek MP, Cohen RA. Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype[J]. Stroke, 2008, 39(3): 814-821
    [107] Love S, Nicoll JA, Hughes A, Wilcock GK. APOE and cerebral amyloid angiopathy in the elderly[J]. Neuroreport, 2003, 14(11): 1535-1536
    [108] 梁勇. 载脂蛋白e与阿尔茨海默病:分子学机制及其治疗机会[J]. 基础医学与临床, 2008,(03): 259
    [109] Batelli S, Albani D, Prato F, Polito L, Franceschi M, Gavazzi A, Forloni G. Early-onset Alzheimer disease in an Italian family with presenilin-1 double mutation E318G and G394V[J]. Alzheimer Dis Assoc Disord, 2008, 22(2): 184-187
    [110] Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease[J]. EMBO Rep, 2009, 10(1): 94-100
    [111] Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, Chiang HC, Hakker I, Zhong Y, Iijima K. Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila[J]. J Biol Chem, 2008,283(27): 19066-19076
    [112] Trembath D, Ervin JF, Broom L, Szymanski M, Welsh-Bohmer K, Pieper C, Hulette CM. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype[J]. Acta Neuropathol, 2007, 113(1): 23-31
    [113] Camicioli R, Kryscio R. Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease[J]. Neurology, 2005, 65(12): 1855-1856
    [114] Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, Blacker D, Stern Y. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease[J]. Neurology, 2008, 70(19 Pt 2): 1842-1849
    [115] Ito S, Ohtsuki S, Kamiie J, Nezu Y, Terasaki T. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes[J]. J Neurochem, 2007, 103(6): 2482-2490
    [116] Berlau DJ, Corrada MM, Head E, Kawas CH. APOE {varepsilon}2 is associated with intact cognition but increased Alzheimer pathology in the oldest old[J]. Neurology, 2009, 72(9): 829-834
    [117] Iadecola C. Rescuing troubled vessels in Alzheimer disease[J]. Nat Med, 2005, 11(9): 923-924
    [118]朱自强.阿尔茨海默氏病与血管基因meox2有关[J].基础医学与临床,2005,(10):924
    [119]Wilhelmus MM,Otte-Holler I,van Triel JJ,Veerhuis R,Maat-Schieman ML,Bu G,de Waal RM,Verbeek MM.Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells[J].Am J Pathol,2007,171(6):1989-1999
    [120]潘静,陈生弟.氧化应激与神经退行性疾病[J].国际神经病学神经外科学杂志,2008,(02):143-145
    [121]Morimoto RI.Stress,aging,and neurodegenerative disease[J].N Engl J Med,2006,355(21):2254-2255
    [122]Tong XK,Nicolakakis N,Kocharyan A,Hamel E.Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease[J].J Neurosci,2005,25(48):11165-11174
    [123]Chong ZZ,Li F,Maiese K.Oxidative stress in the brain:novel cellular targets that govern survival during neurodegenerative disease[J].Prog Neurobiol,2005,75(3):207-246
    [124]Aliyev A,Chen SG,Seyidova D,Smith MA,Perry G,de la Torre J,Aliev G.Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease[J].J Neurol Sci,2005,229-230:285-292
    [125]Miller AA,Drummond GR,Sobey CG.Novel isoforms of NADPH-oxidase in cerebral vascular control[J].Pharmacol Ther,2006,111(3):928-948
    [126]Park L,Anrather J,Zhou P,Frys K,Pitstick R,Younkin S,Carlson GA,Iadecola C.NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide[J].J Neurosci,2005,25(7):1769-1777
    [127]Park L,Anrather J,Girouard H,Zhou P,Iadecola C.Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain[J].J Cereb Blood Flow Metab,2007,27(12):1908-1918
    [128]Iadecola C.Neurovascular regulation in the normal brain and in Alzheimer's disease[J].Nat Rev Neurosci,2004,5(5):347-360
    [129]Shelat PB,Chalimoniuk M,Wang JH,Strosznajder JB,Lee JC,Sun AY,Simonyi A,Sun GY.Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons[J].J Neurochem,2008,106(1):45-55
    [130]Moroni F,Chiarugi A.Post-ischemic brain damage:targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment[J].FEBS J,2009,276(1):36-45
    [131]Zou MH.Peroxynitrite and protein tyrosine nitration of prostacyclin synthase[J].Prostaglandins Other Lipid Mediat,2007,82(1-4):119-127
    [132]Park L,Zhou P,Pitstick R,Capone C,Anrather J,Norris EH,Younkin L,Younkin S,Carlson G,McEwen BS,Iadecola C.Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein[J].Proc Natl Acad Sci U S A,2008,105(4):1347-1352
    [133]Krummen S,Drouin A,Gendron ME,Falck JR,Thorin E.ROS-sensitive cytochrome P450 activity maintains endothelial dilatation in ageing but is transitory in dyslipidaemic mice[J].Br J Pharmacol,2006,147(8):897-904
    [134]Guix FX,Uribesalgo I,Coma M,Munoz FJ.The physiology and pathophysiology of nitric oxide in the brain[J].Prog Neurobiol,2005,76(2):126-152
    [135]Kunz A,Park L,Abe T,Gallo EF,Anrather J,Zhou P,Iadecola C.Neurovascular protection by ischemic tolerance:role of nitric oxide and reactive oxygen species[J].J Neurosci, 2007, 27(27): 7083-7093
    [136] Kitaura H, Uozumi N, Tohmi M, Yamazaki M, Sakimura K, Kudoh M, Shimizu T, Shibuki K. Roles of nitric oxide as a vasodilator in neurovascular coupling of mouse somatosensory cortex[J]. Neurosci Res, 2007, 59(2): 160-171
    [137] Limon ID, Diaz A, Mendieta L, Chamorro G, Espinosa B, Zenteno E, Guevara J. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats[J]. Neurosci Res, 2009, 63(2): 129-137
    [138] Phares TW, Fabis MJ, Brimer CM, Kean RB, Hooper DC. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient[J]. J Immunol, 2007, 178(11): 7334-7343
    [139] Thinakaran G, Sisodia SS. Presenilins and Alzheimer disease: the calcium conspiracy [J]. Nat Neurosci, 2006, 9(11): 1354-1355
    [140] Fujita T. [Alzheimer disease and calcium][J]. Clin Calcium, 2004, 14(1): 103-105
    [141] Conley YP, Mukherjee A, Kammerer C, Dekosky ST, Kamboh MI, Finegold DN, Ferrell RE. Evidence supporting a role for the calcium-sensing receptor in Alzheimer disease[J]. Am J Med Genet B Neuropsychiatr Genet, 2008:
    [142] Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease[J]. J Neurol Sci, 2005, 229-230: 37-41
    [143] Gordon-Krajcer W, Kozniewska E, Lazarewicz JW, Ksiezak-Reding H. Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils[J]. Neurochem Res, 2007, 32(4-5): 729-737
    [144] Wen Y, Yang SH, Liu R, Perez EJ, Brun-Zinkernagel AM, Koulen P, Simpkins JW. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats[J]. Biochim Biophys Acta, 2007, 1772(4): 473-483
    [145] Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer's disease[J]. Neurotherapeutics, 2008, 5(3): 409-414
    [146] Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L, Villarreal-Calderon R, Osnaya N, Stone I, Garcia R, Brooks DM, Gonzalez-Maciel A, Reynoso-Robles R, Delgado-Chavez R, Reed W. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults[J]. Toxicol Pathol, 2008, 36(2): 289-310
    [147] Ji Y, Permanne B, Sigurdsson EM, Holtzman DM, Wisniewski T. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice[J]. J Alzheimers Dis, 2001, 3(1): 23-30
    [148] Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model[J]. J Clin Invest, 2005, 115(11): 3285-3290
    [149] Chen JJ, Ly AV. Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease[J]. Am J Health Syst Pharm, 2006, 63(10): 915-928
    [150] Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration[J]. Trends Neurosci, 2005, 28(4): 202-208
    [151] Guo S, Kim WJ, Lok J, Lee SR, Besancon E, Luo BH, Stins MF, Wang X, Dedhar S, Lo EH. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons[J]. Proc Natl Acad Sci U S A, 2008, 105(21): 7582-7587
    [152]Chang CJ,Yu JS,Nelson JS.Confocal microscopy study of neurovascular distribution in facial port wine stains(capillary malformation)[J].J Formos Med Assoc,2008,107(7):559-566
    [153]吕志迈,徐运.脑血管储备与阿尔茨海默病[J].中国卒中杂志,2007,(08):679-683
    [154]Lok J,Gupta P,Guo S,Kim WJ,Whalen MJ,van Leyen K,Lo EH.Cell-cell signaling in the neurovascular unit[J].Neurochem Res,2007,32(12):2032-2045
    [155]Benarroch EE.Neurovascular unit dysfunction:a vascular component of Alzheimer disease?[J].Neurology,2007,68(20):1730-1732
    [156]Brenner SR.Neurovascular unit dysfunction:a vascular component of Alzheimer disease?[J].Neurology,2008,70(3):243-244
    [157]Milner R,Hung S,Wang X,Berg GI,Spatz M,del Zoppo GJ.Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit[J].Stroke,2008,39(1):191-197
    [158]Boulanger E,Puisieux F,Gaxatte C,Wautier JL.[Aging:role and control of glycation[J].Rev Med Interne,2007,28(12):832-840
    [159]Kouznetsova E,Klingner M,Sorger D,Sabri O,Grossmann U,Steinbach J,Scheunemann M,Schliebs R.Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice[J].Int J Dev Neurosci,2006,24(2-3):187-193
    [160]Schultheiss C,Blechert B,Gaertner FC,Drecoll E,Mueller J,Weber GF,Drzezga A,Essler M.In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease[J].Angiogenesis,2006,9(2):59-65
    [161]Price JM,Hellermann A,Hellermann G,Sutton ET.Aging enhances vascular dysfunction induced by the Alzheimer's peptide beta-amyloid[J].Neurol Res,2004,26(3):305-311
    [162]Becker RE,Unni LK,Greig NH.Resurrecting clinical pharmacology as a context for Alzheimer disease drug development[J].Curr Alzheimer Res,2009,6(1):79-81
    [163]Chow N,Bell RD,Deane R,Streb JW,Chen J,Brooks A,Van Nostrand W,Miano JM,Zlokovic BV.Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype[J].Proc Natl Acad Sci U S A,2007,104(3):823-828
    [164]Diaz JC,Simakova O,Jacobson KA,Arispe N,Pollard HB.From the Cover:Small molecule blockers of the Alzheimer A {beta} calcium channel potently protect neurons from A{beta} cytotoxicity[J].Proc Natl Acad Sci U S A,2009,106(9):3348-3353
    [165]Li L,Cao D,Kim H,Lester R,Fukuchi K.Simvastatin enhances learning and memory independent of amyloid load in mice[J].Ann Neurol,2006,60(6):729-739
    [166]Nielsen HM,Londos E,Minthon L,Janciauskiene SM.Soluble adhesion molecules and angiotensin-converting enzyme in dementia[J].Neurobiol Dis,2007,26(1):27-35
    [167]赵敬堃,王德生.中药与中药有效成分治疗阿尔茨海默病的研究进展[J].中国中西医结合杂志,2008,(02):177-181
    [168]李娜,贾芳.人参皂苷治疗阿尔茨海默病作用机制的研究进展[J].医学综述,2008,(17):2691-2693
    [169]Sun K,Wang CS,Guo J,Horie Y,Fang SP,Wang F,Liu YY,Liu LY,Yang JY,Fan JY,Han JY.Protective effects of ginsenoside Rbl,ginsenoside Rg1,and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery[J].Life Sci,2007,81(6):509-518
    [170]Ma ZC,Gao Y,Wang J,Zhang XM,Wang SQ.Proteomic analysis effects of ginsenoside Rgl on human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha[J].Life Sci,2006,79(2):175-181